File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Functional inhibition of lactate dehydrogenase suppresses pancreatic adenocarcinoma progression

TitleFunctional inhibition of lactate dehydrogenase suppresses pancreatic adenocarcinoma progression
Authors
KeywordsAMPK
mTOR pathway
berberine
L-lactate
lactate dehydrogenase
Issue Date2021
PublisherWiley Open Access: Creative Commons Attribution License. The Journal's web site is located at http://www.clintransmed.com
Citation
Clinical and Translational Medicine, 2021, v. 11 n. 6, p. article no. e467 How to Cite?
AbstractBackground: Pancreatic adenocarcinoma (PAAD) a highly lethal malignancy. The current use of clinical parameters may not accurately predict the clinical outcome, which further renders the unsatisfactory therapeutic outcome. Methods: In this study, we retrospectively analyzed the clinical-pathological characteristics and prognosis of 253 PAAD patients. Univariate, multivariate, and Kaplan-Meier survival analyses were conducted to assess risk factors and clinical outcomes. For functional study, we performed bidirectional genetic manipulation of lactate dehydrogenase A (LDHA) in PAAD cell lines to measure PAAD progression by both in vitro and in vivo assays. Results: LDHA is particularly overexpressed in PAAD tissues and elevated serum LDHA-transcribed isoenzymes-5 (LDH-5) was associated with poorer patients’ clinical outcomes. Genetic overexpression of LDHA promoted the proliferation and invasion in vitro, and tumor growth and metastasis in vivo in murine PAAD orthotopic models, while knockdown of LDHA exhibited opposite effects. LDHA-induced L-lactate production was responsible for the LDHA-facilitated PAAD progression. Mechanistically, LDHA overexpression reduced the phosphorylation of metabolic regulator AMPK and promoted the downstream mTOR phosphorylation in PAAD cells. Inhibition of mTOR repressed the LDHA-induced proliferation and invasion. A natural product berberine was selected as functional inhibitor of LDHA, which reduced activity and expression of the protein in PAAD cells. Berberine inhibited PAAD cells proliferation and invasion in vitro, and suppressed tumor progression in vivo. The restoration of LDHA attenuated the suppressive effect of berberine on PAAD. Conclusions: Our findings suggest that LDHA may be a novel biomarker and potential therapeutic target of human PAAD.
Persistent Identifierhttp://hdl.handle.net/10722/301346
ISSN
2023 Impact Factor: 7.9
2023 SCImago Journal Rankings: 2.424
PubMed Central ID
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorCheng, CS-
dc.contributor.authorTan, HY-
dc.contributor.authorWang, N-
dc.contributor.authorChen, L-
dc.contributor.authorMeng, Z-
dc.contributor.authorChen, Z-
dc.contributor.authorFeng, Y-
dc.date.accessioned2021-07-27T08:09:43Z-
dc.date.available2021-07-27T08:09:43Z-
dc.date.issued2021-
dc.identifier.citationClinical and Translational Medicine, 2021, v. 11 n. 6, p. article no. e467-
dc.identifier.issn2001-1326-
dc.identifier.urihttp://hdl.handle.net/10722/301346-
dc.description.abstractBackground: Pancreatic adenocarcinoma (PAAD) a highly lethal malignancy. The current use of clinical parameters may not accurately predict the clinical outcome, which further renders the unsatisfactory therapeutic outcome. Methods: In this study, we retrospectively analyzed the clinical-pathological characteristics and prognosis of 253 PAAD patients. Univariate, multivariate, and Kaplan-Meier survival analyses were conducted to assess risk factors and clinical outcomes. For functional study, we performed bidirectional genetic manipulation of lactate dehydrogenase A (LDHA) in PAAD cell lines to measure PAAD progression by both in vitro and in vivo assays. Results: LDHA is particularly overexpressed in PAAD tissues and elevated serum LDHA-transcribed isoenzymes-5 (LDH-5) was associated with poorer patients’ clinical outcomes. Genetic overexpression of LDHA promoted the proliferation and invasion in vitro, and tumor growth and metastasis in vivo in murine PAAD orthotopic models, while knockdown of LDHA exhibited opposite effects. LDHA-induced L-lactate production was responsible for the LDHA-facilitated PAAD progression. Mechanistically, LDHA overexpression reduced the phosphorylation of metabolic regulator AMPK and promoted the downstream mTOR phosphorylation in PAAD cells. Inhibition of mTOR repressed the LDHA-induced proliferation and invasion. A natural product berberine was selected as functional inhibitor of LDHA, which reduced activity and expression of the protein in PAAD cells. Berberine inhibited PAAD cells proliferation and invasion in vitro, and suppressed tumor progression in vivo. The restoration of LDHA attenuated the suppressive effect of berberine on PAAD. Conclusions: Our findings suggest that LDHA may be a novel biomarker and potential therapeutic target of human PAAD.-
dc.languageeng-
dc.publisherWiley Open Access: Creative Commons Attribution License. The Journal's web site is located at http://www.clintransmed.com-
dc.relation.ispartofClinical and Translational Medicine-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectAMPK-
dc.subjectmTOR pathway-
dc.subjectberberine-
dc.subjectL-lactate-
dc.subjectlactate dehydrogenase-
dc.titleFunctional inhibition of lactate dehydrogenase suppresses pancreatic adenocarcinoma progression-
dc.typeArticle-
dc.identifier.emailWang, N: ckwang@hku.hk-
dc.identifier.emailFeng, Y: yfeng@hku.hk-
dc.identifier.authorityWang, N=rp02075-
dc.identifier.authorityFeng, Y=rp00466-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1002/ctm2.467-
dc.identifier.pmid34185423-
dc.identifier.pmcidPMC8238920-
dc.identifier.scopuseid_2-s2.0-85111169227-
dc.identifier.hkuros323589-
dc.identifier.volume11-
dc.identifier.issue6-
dc.identifier.spagearticle no. e467-
dc.identifier.epagearticle no. e467-
dc.identifier.isiWOS:000667815600035-
dc.publisher.placeUnited Kingdom-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats